QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Efficacy and safety of IBI305 compared with bevacizumab in advanced non-squamous NSCLC patients as first-line treatment in a randomized, double-blind, phase III study. 会议论文 作者:  Zhang, Li;  Wu, Bin;  Huang, Linian;  Shi, Meiqi;  Liu, Yunpeng 收藏  |  浏览/下载：20/0  |  提交时间：2019/12/05 Efficacy and safety of IBI305 compared with bevacizumab in advanced non-squamous NSCLC patients as first-line treatment in a randomized, double-blind, phase III study. 会议论文 作者:  Zhang, Li;  Wu, Bin;  Huang, Linian;  Shi, Meiqi;  Liu, Yunpeng 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05 A WORK-STEALING BASED DYNAMIC LOAD BALANCING ALGORITHM FOR CONSERVATIVE PARALLEL DISCRETE EVENT SIMULATION 会议论文 2017 WINTER SIMULATION CONFERENCE (WSC), 2017-01-01 作者:  Tang Wenjie;  Yao Yiping;  Zhu Feng;  Li Tianlin;  Song Xiao 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/30 Final overall survival and updated biomarker analysis results from the randomized phase III ICOGEN trial. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2012-05-20 作者:  Sun, Yan;  Shi, Yuankai;  Zhang, Li;  Liu, Xiaoqing;  Zhou, Caicun 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/13 A 3-DAY ORAL APREPITANT REGIMEN PROVIDES SUPERIOR PREVENTION OF CINV OVER STANDARD THERAPY IN CHINESE PATIENTS RECEIVING HIGH-DOSE CISPLATIN 会议论文 作者:  Zhang, Li;  Cheng, Ying;  Zhang, Hong-Yu;  Zhou, Caicun;  Han, Baohui 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 high-dose cisplatin  Aprepitant  CINV